Pregabalin in chemotherapy induced neuropathic pain
Open Access
- 1 January 2016
- journal article
- case report
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 22 (1) , 101-103
Abstract
Chemotherapeutic agents belonging to vinca alkaloids, taxanes, and antitubulins produce peripheral neuropathy for which there is no validated treatment. Pregabalin, a gamma-aminobutyric acid analog, is known to inhibit theα2δ subunit of the voltage-gated calcium channel. Earlier studies and case reports have shown pregabalin to be effective in treating neuropathic pain. We present a case series of patients with chemotherapy-induced peripheral neuropathy who were successfully treated with pregabalin with reduction in the hyperalgesia, allodynia, and improvement in the quality of life.Keywords
This publication has 20 references indexed in Scilit:
- A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer PainAmerican Journal of Hospice and Palliative Medicine®, 2011
- Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialAnnals of Oncology, 2011
- Use of Calcium and Magnesium Salts to Reduce Oxaliplatin-Related NeurotoxicityJournal of Clinical Oncology, 2007
- Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disordersClinical Therapeutics, 2007
- Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunitNeuroscience, 2007
- New horizons in the development of antiepileptic drugs: Innovative strategiesEpilepsy Research, 2006
- Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium InfusionsClinical Cancer Research, 2004
- PregabalinDrugs, 2004
- Anticonvulsants for Neuropathic Pain SyndromesDrugs, 2000
- Paclitaxel Delivered as a 3-hr Infusion with Cisplatin in Patients with Gynecologic Cancers: Unexpected Incidence of NeurotoxicityGynecologic Oncology, 1996